BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 7308505)

  • 21. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women.
    Ryu K; Yu HK; Kwak HM; Hong SS
    Contraception; 1983 Mar; 27(3):299-310. PubMed ID: 6406140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some aspects on pituitary function in human and rat anovulatory cycles.
    Makino T; Shiina M; Ohno T; Iizuka R; Tamaoki B
    Endocrinol Jpn; 1976 Dec; 23(6):445-9. PubMed ID: 798684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-tubal sterilization problems correlated with ovarian steroidogenesis.
    Cattanach JF; Milne BJ
    Contraception; 1988 Nov; 38(5):541-50. PubMed ID: 3197418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental studies on the endocrine regulations during the periovulatory phase of the human menstrual cycle. The effects of exogenous 17 -oestradiol and progesterone on the release of pituitary luteinizing and follicle stimulating hormones.
    Leyendecker G; Wardlaw S; Nocke W
    Acta Endocrinol (Copenh); 1972 Sep; 71(1):160-78. PubMed ID: 4678011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
    Laumas V; Jain AK; Jha P; Rahman SA; Kumar D; Malik BK; Sarkar NN; Takkar D; Hingorani V; Laumas KR
    Contraception; 1981 Feb; 23(2):211-25. PubMed ID: 6786828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of ovarian function after tubal sterilization.
    Radwanska E; Headley SK; Dmowski P
    J Reprod Med; 1982 Jul; 27(7):376-84. PubMed ID: 6811740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luteal deficiency among women with normal menstrual cycles, requesting reversal of tubal sterilization.
    Radwanska E; Berger GS; Hammond J
    Obstet Gynecol; 1979 Aug; 54(2):189-92. PubMed ID: 460752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal relationship between Uniplant insertion and changes in cervical mucus.
    Barbosa IC; Coutinho E; Hirsch C; Ladipo OA; Olsson SE; Ulmsten U
    Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of tubal sterilization on ovarian follicular reserve and function.
    Carmona F; Cristóbal P; Casamitjana R; Balasch J
    Am J Obstet Gynecol; 2003 Aug; 189(2):447-52. PubMed ID: 14520216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further studies on pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1981 Aug; 24(2):159-72. PubMed ID: 6794980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
    Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
    Nillius SJ; Bergquist C; Wide L
    Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ovarian function determination in pre and postsurgical sterilization].
    Gabriela Correa G; Enrique Echeverría L; Fernando Bello M
    Rev Chil Obstet Ginecol; 1995; 60(3):184-8. PubMed ID: 8728747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.